We show a SIRT3-Akt-c-Myc signaling axis that underlies the progression of prostate cancer (Figure 7), and suggest that the molecular and pathological determination of SIRT3 may be used in prostate cancer diagnosis/prognosis. Here, MYC is linked to Familial prostate cancer.